EC Number |
Inhibitors |
Structure |
---|
2.5.1.10 | (((2-phenylthieno[2,3-d]pyrimidin-4-yl)amino)methylene)diphosphonic acid |
about 75% inhibition at 0.01 mM |
|
2.5.1.10 | (((5-phenylthieno[2,3-d]pyrimidin-4-yl)amino)methylene)diphosphonic acid |
about 10% inhibition at 0.01 mM |
|
2.5.1.10 | (((6-(4-tolyl)thieno[2,3-d]pyrimidin-4-yl)amino)methylene)diphosphonic acid |
about 85% inhibition at 0.01 mM |
|
2.5.1.10 | (((6-(naphthalen-2-yl)thieno[2,3-d]pyrimidin-4-yl)amino)methylene)diphosphonic acid |
about 87% inhibition at 0.01 mM |
|
2.5.1.10 | (1-hydroxyheptane-1,1-diyl)bis(phosphonic acid) |
- |
|
2.5.1.10 | (2-[[(2E)-2,6-dimethylhepta-2,5-dien-1-yl]amino]ethane-1,1-diyl)bis(phosphonic acid) |
- |
|
2.5.1.10 | (2R,4aS,6aS,12bR,14aS)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid |
- |
|
2.5.1.10 | (4bR,8aS)-4b-(5-acetyl-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-5,6,7,8,8a,9-hexahydrophenanthrene-3,4,10(4bH)-trione |
- |
|
2.5.1.10 | (4bR,8aS)-4b-(5-amino-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-3,4-diol |
- |
|
2.5.1.10 | (4bR,8aS)-4b-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8,8-dimethyl-2-(propan-2-yl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-3,4-diol |
- |
|